Page 9 - Sanket Koul

Metropolis Q2 results: Profit up 13% on higher patient, test volumes

Metropolis Healthcare posted a 13% rise in Q2FY26 net profit to ₹53 crore, driven by increased patient and test volumes, network expansion, and improved performance across regions

Alembic Pharma Q2 profit rises 21% on robust US generics and API growth

Alembic Pharma's consolidated profit rose 21% to Rs 185 crore in Q2 FY26, led by strong performance in US generics, APIs, and international markets, with six new ANDA approvals

Smartworks rents 815,000 sq. ft office space from Hiranandani Group

Smartworks has leased 815,000 sq ft from the Hiranandani Group's Eastbridge campus in Mumbai to build what it calls the world's largest managed workspace, set to open in late 2026

Alkem Foundation and IIT Bombay collaborate for advanced research centre

Alkem Foundation will contribute 20 to 25 per cent of its cumulative CSR obligations over seven years to this research centre

DLF eyes luxury launches, to begin rental income from malls in near term

Real estate giant DLF plans new luxury project launches across Goa, Mumbai and Gurugram, while expecting rental income from its upcoming malls Midtown Plaza, Summit Plaza and DLF Promenade soon

Developers' housing focus deepens office space shortage: Knight Frank

Knight Frank-CII report says India's top developers are prioritising residential projects over office spaces due to higher margins and quicker returns, causing supply imbalances

Dr Lal PathLabs Q2 results: PAT up 16.4% at ₹152 crore, revenue rises 11%

Diagnostics chain declares ₹7 per share interim dividend, 1:1 bonus issue

DLF Q2 profit down 15%, revenue falls 17% despite sales performance

According to the company's consolidated balance sheet, this drop could be attributed to rising overall tax expenses.

Canada notice may delay Dr Reddy's semaglutide generic launch

Health Canada's non-compliance notice may delay DRL's semaglutide generic launch by 8-12 months, say analysts; shares fall over 4 per cent on Thursday

Centre brings draft rules to debar drugmakers who provide fake information

At present, there is no provision under Drugs Rules, 1945 to address issues of wrong information to obtain regulatory approvals

India's pharma, healthcare deals surge 166% to $3.5 bn in Q3: Report

Grant Thornton Bharat says India's pharma and healthcare sectors saw renewed investor confidence, driven by consolidation across pharma, biotech, and hospital segments

Signature Global raises ₹875 cr via IFC NCDs to fund housing, repay debt

The Delhi NCR-based developer will use the funds to develop mid-income and ESG-aligned housing projects, repay Rs 470 crore of debt, and strengthen its balance sheet

After foreign universities, international school boards look to tap India

International school boards IB, Cambridge, and WACE expand in India with teacher training, affordable programs, and growth beyond metros to Tier-2 and Tier-3 cities

CDSCO flags cough syrup as spurious, 112 drugs fail quality tests

The central drug regulator found one spurious cough syrup and 112 substandard formulations during its September 2025 checks, triggering detailed scrutiny

Luxe breathes easy: Clean air homes are in demand amid rising air pollution

Premiums rise as AQI-assured homes attract eco-conscious buyers

CDSCO issues draft guidelines to regulate medical device software

Draft guidelines aim to align India's medtech software framework with global practices; industry seeks more clarity on AI/ML evaluation and algorithm change management

Hospitals see spike in respiratory cases; air pollution may worsen in NCR

Delhi-NCR hospitals report a sharp spike in breathing-related cases as air quality turns 'severe' after Diwali; doctors expect numbers to rise in coming days

Realty developers see a cracker of sales in key cities this festival season

Festive cheer sustains housing market momentum amid broader headwinds

Govt to tighten rules for sale of oral formulations containing alcohol

Health Ministry also mandates QR codes on vaccines and anti-cancer meds, eases sales licence norms for liquid antiseptics

M3M to invest ₹2,100 cr in Jacob & Co's branded housing debut in India

M3M Group partners with luxury watchmaker Jacob & Co to build India's first branded residences in Noida, with an investment of Rs 2,100 crore and prices up to Rs 25 crore